Registration is now OPEN for the first-ever UN high-level Meeting on TB
29 June 2018, Geneva - Registration is now open for the first-ever UN High Level Meeting (UNHLM) on TB, which will be held on 26 September 2018 in New York. The UNHLM will be held on the theme ?United to end tuberculosis: an urgent global response to a global epidemic?, and will bring together Heads of State to commit to accelerated action to end TB.
 2018/07/08 - Comments : ٠more ... >>
Countdown to the first-ever UN High-Level Meeting on TB
27 June 2018, Geneva - Only 90 days are left to the first-ever UN High-Level Meeting (UNHLM) on TB, which will bring together Heads of State in New York on 26 September 2018. Now is the time for everyone to engage, support, amplify messages and work to ensure a very successful event in September. The World Health Organization (WHO) and the Stop TB Partnership together with partners are working to rally highest level participation and a strong political declaration for a successful and impactful UNHLM.
 2018/07/07 - Comments : ٠more ... >>
Water-limited landscapes can facilitate disease transmission
In water-limited landscapes sick animals can have increased contact with healthy individuals, which can facilitate disease transmission. Scientists from the German Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) present these findings in the British Ecological Society journal Functional Ecology.
 2018/07/04 - Comments : ٠more ... >>
New study shows how vitamin A effectively supports lung immunity against TB
Scientists at Trinity College Dublin and St James's Hospital, Dublin, have discovered how vitamin A drives the lung immune system to deal with tuberculosis (TB). The findings have just been published in a top respiratory journal, the American Journal of Respiratory Cell and Molecular Biology.
 2018/07/02 - Comments : ٠more ... >>
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice
Researchers have discovered that an FDA-approved drug designed to treat cancer helps fight tuberculosis in mouse models. The drug is an MMP inhibitor designed to increase the structural integrity of blood vessels in tumors so that other drugs can reach inside them. It performs the same function in the granulomas associated with tuberculosis so that antibiotics can reach the bacteria sheltering within.
 2018/07/01 - Comments : ٠more ... >>

<< Previous/e: not exist1 2 3 4 5 6 7 8 9 10 11 Next Page >>





Copyright © 2013 MRC.SBMU.AC.IR
Powered By NRITLD IT Department

آمار بازدیدکنندگان
بازدید از این صفحه : 44536 بار
بازديدکنندگان امروز : 70 نفر
کل بازديدکنندگان : 115631 نفر
بازديدکنندگان آنلاين : 5 نفر